- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment with gefitinib after erlotinib-induced liver injury: a case report ; volume:5 ; number:1 ; day:21 ; month:12 ; year:2011 ; pages:1-3 ; date:12.2011
Journal of medical case reports ; 5, Heft 1 (21.12.2011), 1-3, 12.2011
- Creator
-
Nakatomi, Katsumi
- Contributor
-
Nakamura, Yōichi
Tetsuya, Iida
Kohno, Shigeru
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-5-593
- URN
-
urn:nbn:de:1111-2016071020728
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nakatomi, Katsumi
- Nakamura, Yōichi
- Tetsuya, Iida
- Kohno, Shigeru
- SpringerLink (Online service)
Other Objects (12)
Entwicklung einer medikamentenfreisetzenden Intraokularlinse mit den EGFR-Inhibitoren Erlotinib und Gefitinib
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
Enoxaparin-Induced Liver Injury
Vedolizumab-Induced Liver Injury
In vitro-Untersuchungen zur Wirksamkeit von Erlotinib, Gefitinib und Cetuximab bei der Behandlung des Kopf-Hals-Karzinoms : = In-vitro study on erlotinib, gefitinib and cetuximab responsiveness in head and neck cancer cell lines
Amiodarone-Induced Acute Liver Injury
Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Gut-liver crosstalk in sepsis-induced liver injury
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro
In vitro-Untersuchungen zur Wirksamkeit von Erlotinib, Gefitinib und Cetuximab bei der Behandlung des Kopf-Hals-Karzinoms
Entwicklung einer medikamentenfreisetzenden Intraokularlinse mit den EGFR-Inhibitoren Erlotinib und Gefitinib
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
Enoxaparin-Induced Liver Injury
Vedolizumab-Induced Liver Injury
In vitro-Untersuchungen zur Wirksamkeit von Erlotinib, Gefitinib und Cetuximab bei der Behandlung des Kopf-Hals-Karzinoms : = In-vitro study on erlotinib, gefitinib and cetuximab responsiveness in head and neck cancer cell lines
Amiodarone-Induced Acute Liver Injury
Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Gut-liver crosstalk in sepsis-induced liver injury
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro
In vitro-Untersuchungen zur Wirksamkeit von Erlotinib, Gefitinib und Cetuximab bei der Behandlung des Kopf-Hals-Karzinoms
Entwicklung einer medikamentenfreisetzenden Intraokularlinse mit den EGFR-Inhibitoren Erlotinib und Gefitinib
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
Enoxaparin-Induced Liver Injury
Vedolizumab-Induced Liver Injury
In vitro-Untersuchungen zur Wirksamkeit von Erlotinib, Gefitinib und Cetuximab bei der Behandlung des Kopf-Hals-Karzinoms : = In-vitro study on erlotinib, gefitinib and cetuximab responsiveness in head and neck cancer cell lines
Amiodarone-Induced Acute Liver Injury
Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Gut-liver crosstalk in sepsis-induced liver injury
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro